SYNCOM FORMULATIONS (INDIA)
|
The Current P/S Ratio of SYNCOM FORMULATIONS (INDIA) is 6.21.
Share Price | ₹21.8 | Dec 12,2024 |
Market Cap | ₹2,045.4 Cr | |
Sales-TTM | ₹329.3 Cr | TTM-Consolidated Results |
Price/Sales | 6.21x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SYNCOM FORMULATIONS (INDIA)
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,045.4 Cr] as on Dec 12,2024
(/) Sales [ ₹329.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 6.21x ]
Thus, for SYNCOM FORMULATIONS (INDIA) , the investors are currently willing to pay '6.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SYNCOM FORMULATIONS (INDIA) !
The chart below summarizes the trend in P/S Ratio of SYNCOM FORMULATIONS (INDIA) over the last five years.
Historical PS (Price/Sales) ratio chart of SYNCOM FORMULATIONS (INDIA)
PS Ratio Performance Analysis for SYNCOM FORMULATIONS (INDIA)
- SYNCOM FORMULATIONS (INDIA) 's p/e ratio for fiscal years ending Mar2024 to Mar2016 averaged 2.48x.
- SYNCOM FORMULATIONS (INDIA) 's operated at median p/e ratio of 2.47x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SYNCOM FORMULATIONS (INDIA) 's p/e ratio peaked in Mar2022 at 4.17x.
- SYNCOM FORMULATIONS (INDIA) 's p/e ratio hit its five-year low in Mar2017 of 0.83x.
How does SYNCOM FORMULATIONS (INDIA) 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SYNCOM FORMULATIONS (INDIA) | 329.3 | 6.21 | 2,045.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.61 | 432,948.0 |
CIPLA LTD | 26,512.0 | 4.41 | 116,809.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.46 | 103,963.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.57 | 98,173.2 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.33 | 157,873.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.64 | 106,198.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 10.04 | 112,643.0 |
LUPIN LTD | 21,431.3 | 4.51 | 96,581.6 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.33 | 70,576.1 |
ABBOTT INDIA LTD | 6,066.1 | 10.06 | 61,032.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SYNCOM FORMULATIONS (INDIA) 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.33x |
Max industry PS | 18.33x |
Median industry PS | 6.21x |
Average industry PS | 7.47x |
You may also like the below Video Courses